Wedbush analyst David Nierengarten maintained a Buy rating on Oric Pharmaceuticals (ORIC – Research Report) today and set a price target of $20.00. The company’s shares closed yesterday at $12.54.

In a report released today, Scott Devitt from Wedbush maintained a Buy rating on Pinterest (PINS – Research Report), with a price target of ...

Roblox stock is down Thursday after the gaming company came up short on key metrics for its fourth quarter. Here's what you ...

Roblox forecast annual bookings below estimates on Thursday, sparking fears that growth at the videogame platform was slowing ...